Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) program

Ducharme, A. et al. (2006) Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) program. American Heart Journal, 151(5), pp. 985-991.

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McMurray, Professor John
Authors: Ducharme, A., Swedberg, K., Pfeffer, M., Cohen-Solal, A., Granger, C., Maggioni, A., Michelson, E., McMurray, J., Olsson, L., Rouleau, J., Young, J., Olofsson, B., Puu, M., Yusuf, S., and Invest, C.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
College of Medical Veterinary and Life Sciences
Journal Name:American Heart Journal
ISSN:0002-8703

University Staff: Request a correction | Enlighten Editors: Update this record